These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20008745)

  • 1. Summaries for patients. Chronic health problems seem to influence the relationship of blood sugar control and cardiovascular events in patients with type 2 diabetes.
    Ann Intern Med; 2009 Dec; 151(12):I54. PubMed ID: 20008745
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of glycemia management in the prevention of cardiovascular disease--starting over?
    Nathan DM
    Ann Intern Med; 2009 Dec; 151(12):888-9. PubMed ID: 20008764
    [No Abstract]   [Full Text] [Related]  

  • 3. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study.
    Greenfield S; Billimek J; Pellegrini F; Franciosi M; De Berardis G; Nicolucci A; Kaplan SH
    Ann Intern Med; 2009 Dec; 151(12):854-60. PubMed ID: 20008761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How low to go? Blood glucose and heart health.
    Diabetes Forecast; 2008 Apr; 61(4):21. PubMed ID: 18478637
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries for patients. The relationship between blood sugar control and cardiovascular disease in patients with diabetes.
    Ann Intern Med; 2004 Sep; 141(6):I21. PubMed ID: 15381537
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperglycemia and cardiovascular risk in NIDDM.
    Uusitupa MI; Niskanen LK
    Diabetes Care; 1995 Jun; 18(6):884-5. PubMed ID: 7555522
    [No Abstract]   [Full Text] [Related]  

  • 7. Summaries for patients. Control of blood sugar in type 2 diabetes: a guidance statement from the American College of Physicians.
    Ann Intern Med; 2007 Sep; 147(6):I52. PubMed ID: 17876018
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries for patients. The relationship between blood sugar levels and cardiovascular disease.
    Ann Intern Med; 2004 Sep; 141(6):I12. PubMed ID: 15381536
    [No Abstract]   [Full Text] [Related]  

  • 9. Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.
    Östgren CJ; Sundström J; Svennblad B; Lohm L; Nilsson PM; Johansson G
    Diabet Med; 2013 May; 30(5):e170-7. PubMed ID: 23350893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].
    Lambiel J; Fumeaux T
    Rev Med Suisse; 2008 Aug; 4(166):1734. PubMed ID: 18777740
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
    Füchtenbusch M; Hummel M
    MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycemic control and CAD risk: a heretical thought.
    Orchard TJ
    Diabetes Care; 1999 Jul; 22(7):1220. PubMed ID: 10388997
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.
    Thomas G; Khunti K; Curcin V; Molokhia M; Millett C; Majeed A; Paul S
    Diabetes Obes Metab; 2014 Apr; 16(4):317-25. PubMed ID: 24118783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What matters in ADVANCE and ADVANCE-ON.
    Hamet P
    Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():20-9. PubMed ID: 22118707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visit-to-Visit HbA
    Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
    Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice.
    Reutens AT; Hutchinson R; Van Binh T; Cockram C; Deerochanawong C; Ho LT; Ji L; Khalid BA; Kong AP; Lim-Abrahan MA; Tan CE; Tjokroprawiro A; Yoon KH; Zimmet PZ; Shaw JE
    Diabetes Res Clin Pract; 2012 Oct; 98(1):38-45. PubMed ID: 22784926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case study 1: exploring the pharmacologic agents for treatment of type 2 diabetes.
    Martin CL
    Diabetes Educ; 2007; 33 Suppl 1():6S-13S. PubMed ID: 17272803
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial: response to Cukierman-Yaffe et al.
    Abbatecola AM; Paolisso G
    Diabetes Care; 2009 Aug; 32(8):e102; author reply e103. PubMed ID: 19638518
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose control and vascular complications in veterans with type 2 diabetes.
    Duckworth W; Abraira C; Moritz T; Reda D; Emanuele N; Reaven PD; Zieve FJ; Marks J; Davis SN; Hayward R; Warren SR; Goldman S; McCarren M; Vitek ME; Henderson WG; Huang GD;
    N Engl J Med; 2009 Jan; 360(2):129-39. PubMed ID: 19092145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.
    Chu NV; Kong AP; Kim DD; Armstrong D; Baxi S; Deutsch R; Caulfield M; Mudaliar SR; Reitz R; Henry RR; Reaven PD
    Diabetes Care; 2002 Mar; 25(3):542-9. PubMed ID: 11874944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.